{
  "title": "Metabolic Characteristics of Newer Second-Generation Antipsychotics",
  "itunes:title": "Metabolic Characteristics of Newer Second-Generation Antipsychotics",
  "pubDate": "Mon, 17 Jan 2022 17:00:00 +0000",
  "guid": "b930263d-7004-4885-b554-ba7055725a14",
  "link": "https://psychopharmacology.libsyn.com/metabolic-characteristics-of-newer-second-generation-antipsychotics",
  "itunes:image": "",
  "description": "<p>What was the difference among antipsychotics? Over 1 year, lurasidone caused no net weight gain, whereas olanzapine caused a gain of 10 pounds. Perphenazine was associated with a 2 lb. loss vs olanzapine's 9.5 lb. gain.</p> <p>Faculty: Jim Phelps, M.D.<br /> Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><strong><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC135\"> Learn more about our memberships here</a></strong></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/quick-take-vol-30-2604?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC135\"> <strong>Earn 0.5 CMEs: Quick Take Vol. 30</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/comparison-of-the-metabolic-characteristics-of-newer-second-generation-antipsychotics-2604-5083?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC135\"> <strong>Comparison of the Metabolic Characteristics of Newer Second-Generation Antipsychotics</strong></a></li> </ul>",
  "content:encoded": "<p>What was the difference among antipsychotics? Over 1 year, lurasidone caused no net weight gain, whereas olanzapine caused a gain of 10 pounds. Perphenazine was associated with a 2 lb. loss vs olanzapine's 9.5 lb. gain.</p> <p>Faculty: Jim Phelps, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC135\"> Learn more about our memberships here</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/quick-take-vol-30-2604?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC135\"> Earn 0.5 CMEs: Quick Take Vol. 30</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/comparison-of-the-metabolic-characteristics-of-newer-second-generation-antipsychotics-2604-5083?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC135\"> Comparison of the Metabolic Characteristics of Newer Second-Generation Antipsychotics</a></li> </ul>",
  "enclosure": "",
  "itunes:duration": "10:09",
  "itunes:explicit": false,
  "itunes:keywords": "",
  "itunes:subtitle": "What was the difference among antipsychotics? Over 1 year, lurasidone caused no net weight gain, whereas olanzapine caused a gain of 10 pounds. Perphenazine was associated with a 2 lb. loss vs olanzapine's 9.5 lb. gain. Faculty: Jim Phelps, M.D....",
  "itunes:episodeType": "full"
}